Sales in Image Guided Surgery Devices Market will double as Demand for Minimally Invasive Surgical Procedures Grows
10 Nov 2021
AcquisitionCollaborate
Sales to Surpass US$ 8.1 Bn as Image-Guided Surgery Devices Become Standard of Care for Managing Neurological Disorders
The latest study on image guided surgery devices market by Fact.MR provides a meticulous analysis of prevailing dynamics, current developments affecting growth in the market, and trending business strategies. It studies various growth drivers, opportunities and challenges affecting the demand across leading segments in terms of device, application, and end user.
Fact.MR – A Market Research and Competitive Intelligence Provider: As per Fact.MR, the image guided surgery devices market is expected to reach US$ 4 Bn in 2021. With rising preference for minimally invasive surgeries and increasing prevalence of chronic diseases, the overall market is projected to register CAGR of 7.3% between 2021 and 2031, totaling US$ 8.1 Bn by 2031.
Advent of image guided surgery devices has completely transformed the modern surgical techniques. These devices facilitate greater accuracy during surgery, decrease procedure time, reduce complexity, and minimize risks of tissue damage.
Image guided surgery devices are mostly useful in performing complicated surgeries where there is maximum chance of tissue damage and threat to patient’s safety. Hence, they help in conducting safer and less invasive procedures.
The growing popularity of computer assisted surgery is projected to accelerate the growth of image guided surgery devices market during the forecast period. Integration of modern technologies such as augmented and virtual reality into image-guided surgery (IGS) also will boost the market through the forecast period. Demand for computed tomography (CT) scanners are expected to lead the market share.
Request a report sample to gain compressive insights at
As per Fact.MR, the demand for image guided surgery devices for neurosurgery is expected to increase at 6.5% CAGR between 2021 and 2031.
Application of image guided surgery devices will rise in the treatment of neurosurgical disorders. Use of these devices enables improved precision during surgeries, reducing the risk of causing damage to non-surgery areas. Application of image guided surgery devices for oncology and neurosurgery to remain dominant throughout the forecast period.
According to the report, China is expected to register the fastest growth on the back of surging demand for minimally invasive surgical procedures, rising cases of chronic diseases, and increasing government support.
“Rising availability of advanced image guided surgery devices across emerging economies is paving way for the growth of the market. Governments and private organizations alike are investing in modernizing healthcare infrastructure. This is expected to create lucrative opportunities for growth of the market over the coming years,” says the Fact.MR analyst
Key Takeaways from Image Guided Surgery Devices Market Survey
With increasing prevalence of chronic diseases such as cancer and tumor, rising governmental support, and advancements in medical technology, demand in China is set to expand at a CAGR of 7% through 2031.
The U.S. market is slated to grow by 6% CAGR between 2021 and 2031, owing to the rising preference for minimally invasive surgical procedures.
Based on device type, demand for computed tomography (CT) scanners is anticipated to grow at 6.5% CAGR through 2031.
In terms of application, demand in the oncology segment is expected to grow at 7% CAGR during the forecast period.
Key Drivers
Increasing prevalence of chronic diseases such as cancer and stroke is augmenting the demand for image guided devices.
Growing popularity of minimally invasive surgical procedures across the globe will continue to improve the sales of image guided surgery devices.
To learn more about Image Guided Surgery Devices Market, you can get in touch with our Analyst at
Competitive Landscape
Companies operating in the image guided surgery devices market are focusing on launching novel devices, integrated with the latest technologies. They have adopted various growth strategies such as new product launches, acquisitions, collaborations, and partnerships with healthcare and government organizations to expand their global footprint.
In February 2021, Royal Philips introduced ClarifEye augmented reality surgical navigation, to advance minimally invasive spine procedures in the hybrid operating room. The new solution combines superb 2D and 3D visualizations at low X-ray dose with augmented reality (AR) to provide live intra-operative visual feedback for accurate placement of pedicle screws during spinal fusion procedures.
In April 2021, Erbe Elektromedizin GmbH announced that it will acquire Maxer Endoscopy. This acquisition will help the company to become a solution provider for surgeries and procedures where visualization is critical.
In March 2021, GE Healthcare announced 510(K) clearances of OEC 3D, a new surgical imaging system capable of 3D and 2D imaging, from U.S. Food and Drug Administration (FDA).
Some of the prominent players operating in the image guided surgery devices market profiled by Fact.MR are:
GE Healthcare
Medtronic Plc.
Olympus Corporation
Siemens Healthineers
Koninklijke Philips N.V.
Analogic Corporation
Brainlab AG
Karl Storz Gmbh & Co. KG
Stryker Corporation
Varian Medical Systems Inc.
More Insights on the Global Image Guided Surgery Devices Sales Outlook
Fact.MR offers compelling insights on image guided surgery devices market, presenting historical demand data (2016-2020) and forecast statistics for the period from 2021-2031. The study provides incisive coverage on the global demand for image guided surgery devices with a detailed segmentation on the basis of:
Device Type
Computed Tomography (CT) Scanners
Ultrasound Systems
Magnetic Resonance Imaging (MRI)
Endoscopes
X-ray Fluoroscopy
Position Emitted Tomography (PET)
Single Photon Emission Computed Tomography (SPECT)
Application
Cardiac Surgery
Neurosurgery
Orthopedic Surgery
Urology
Gastroenterology
Oncology Surgery
Other Applications
End User
Hospitals
Ambulatory Surgery Centers
Clinics
Research & Academic Institutions
Key Questions Covered in the Image Guided Surgery Devices Market Outlook Report
The report offers insight into image guided surgery devices demand outlook for 2021-2031
The market study also highlights projected sales growth for image guided surgery devices market between 2021 and 2031
Image guided surgery devices market survey identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry
Image guided surgery devices market share analysis of the key companies within the industry and coverage of strategies such as mergers & acquisitions, joint ventures, collaborations or partnerships, and others
Explore Fact.MR’s Coverage on the Healthcare Domain –
Handheld Fluorescence Imaging Devices Market- The key reason driving the growth of the handheld fluorescence imaging devices market is the rising incidence of breast cancer and chronic diseases around the world. The increased incidence of breast cancer has redirected researchers' attention to more advanced technologies, such as a novel imaging tool that increases tumor visualization during the initial surgery for breast cancer, resulting in the expansion of the handheld fluorescent imaging equipment market. Another influencer of the handheld fluorescence imaging device market is technological and methodology advancements.
Ultrasound Systems Market- Over the last few years, demand for ultrasound systems has continuously increased, with manufacturers responding by incorporating cutting-edge technologies. Ultrasound system vendors have seen substantial growth in the previous five years, thanks to developments in hospitals and diagnostic centers, as well as a surge in demand for 2D, 3D, and 4D ultrasound. As demand for ultrasound systems grows in a variety of applications such as cardiology, radiology, gynecology, and vascular surgery, to mention a few, profit for ultrasound system makers is expected to grow even more in the coming years.
Medical Device Technologies Market- Today, MI operations are gaining popularity, notably in the treatment of cancer, particularly solid tumors. These operations have fewer problems, lower the risk of infection, are less painful, and take less time to recover from. As a result of these benefits, their usage has expanded, boosting the medical device technologies market's growth prospects. Medical device technologies will continue to be influenced by technological advances such as mHealth devices, continuous glucose monitoring systems, and insulin administration systems.
About Fact.MR
Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to healthcare, technology to even the most niche categories. 80% of Fortune 1000's trust us in critical decision making.
MarketNgage is powered by Fact.MR – our Unified Intelligence Engine, a revolutionary Market Research Subscription platform with a flexible pricing to suit your needs.
You can access all our healthcare research reports by signing up with MarketNgage’s Market Research Subscription with FREE credits. MarketNgage is powered by Fact.MR – A Fully integrated research solution for seamless single-window access Widest coverage on emerging markets, nascent products, and disruptive technologies.
Contact:
Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Source: Fact.MR
Organizations
Indications
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.